| D68.0 | Von Willebrand's disease |
| D68.1 | Hereditary factor XI deficiency |
| D68.2 | Hereditary deficiency of other clotting factors |
| D68.3 | Hemorrhagic disorder due to circulating anticoagulants |
| D68.31 | Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
| D68.311 | Acquired hemophilia |
| D68.312 | Antiphospholipid antibody with hemorrhagic disorder |
| D68.318 | Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
| D68.32 | Hemorrhagic disorder due to extrinsic circulating anticoagulants |
| D68.4 | Acquired coagulation factor deficiency |
| D68.5 | Primary thrombophilia |
| D68.51 | Activated protein C resistance |
| D68.52 | Prothrombin gene mutation |
| D68.59 | Other primary thrombophilia |
| D68.6 | Other thrombophilia |
| D68.61 | Antiphospholipid syndrome |
| D68.62 | Lupus anticoagulant syndrome |
| D68.69 | Other thrombophilia |
| D68.8 | Other specified coagulation defects |
| D68.9 | Coagulation defect, unspecified |